Canalys:小米(01810.HK)次季手機出貨量首次躋身全球第二 超越蘋果
調查機構Canalys發表的報告指,今年第二季全球智能手機出貨量升12%,主要受惠疫苗在全球推出,經濟及市民新常態亦逐步成形,期內三星市佔率排第一,達19%,出貨量按年升15%,而小米(01810.HK)首次躋身全球第二位,市佔率17%,出貨量按年升83%。而蘋果(AAPL.US)則以14%市佔率屈居第三,出貨量僅按年升1%。
該行的分析認爲小米海外業務增長快速,其中拉丁美洲的出貨量升逾300%,非洲升150%,而西歐則升50%,隨着公司增長及演變,小米的商業模式正由行業挑戰者轉爲參與者,並有採取措施與渠道夥伴整合,同時小心管理公開市場的舊庫存。不過與三星及蘋果比較,小米的平均銷售單價分別低40%及75%,所以小米今年其中主要目標是要提升高端設備的銷售,惟同業Oppo及Vivo亦有相似的目標,並願意在營銷上花費更多。(el/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.